Google's quest to reinvent artificial intelligence in light of recent breakthroughs and challenges has gained momentum with the launch of a new initiative focused on combating AI misuse in biology. In an update, the company's DeepMind division and Isomorphic Labs revealed their efforts to create a bioresilience program aimed at curbing the spread of biological hazards while supporting emergency response procedures.
The joint initiative, which began quietly but has now expanded significantly over the past 12 months, involves partnerships with government bodies, biosecurity organizations, and research groups. As part of this effort, DeepMind and Isomorphic Labs have established more than 15 such collaborations across various disciplines, enabling a collective commitment to ensuring the integrity of biological systems.
The bioresilience program seeks to strengthen AI capabilities in fields like biotechnology, synthetic biology, and pharmaceuticals, all while promoting robust research and development practices that can mitigate potential risks. By fostering greater transparency and accountability within the AI ecosystem, Google aims to safeguard human health and wellbeing amidst emerging technological advancements.